Leukemia Clinical Trials in Cleveland

Showing 1261-1280 of 1,720 trials

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

NCT01203423

This study was an observational study to estimate the prevalence of Persistent pulmonary hypertension of the newborn (PPHN) among term or near-term infants with severe respiratory disease.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+3 more

NICHD Neonatal Research Network385 participantsStarted Oct 1993

Palo Alto, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +10 more locations

COMPLETED< 1 mile

Early Diagnosis of Candidiasis in Premature Infants

NCT00109525

This observational study evaluated the performance of new lab tests in detecting candida species fungal infections in extremely low birth weight (ELBW) infants quickly and accurately. 19 NICHD Neonatal Research Network sites enrolled 1,500 infants with birth weights ≤1,000g; 100 of these infants later tested positive for candidiasis. Blood, urine, and lumbar puncture samples were collected whenever other specimens were obtained from participants for cultures. These samples are being tested using the new methods and compared with standard culture results. Surviving study subjects completed a neurodevelopmental evaluation at 18-22 months corrected age.

InfectionCandidaCandidiasis+4 more

NICHD Neonatal Research Network1,500 participantsStarted Mar 2004

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +17 more locations

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Early Diagnosis of Candidiasis in Premature Infants

Leukemia Trials in Other Cities

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients

Comparison Air Versus Carbon Dioxide Insufflation in Single Balloon Anterograde Enteroscopy

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula

Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Other Conditions in Cleveland